Barbiturates on Kinetex 2.6u EVO C18 50X2.1 mm
LC Conditions
Column
Kinetex 2.6 µm EVO C18 100 Å, LC Column 50 x 2.1 mm, Ea
Brand
Kinetex
Part No
00B-4725-AN
Phase Name
EVO C18
Elution Type
Gradient
Mobile Phase
A: 10mM Ammonium bicarbonate pH 10
B: Acetonitrile
Gradient Profile
Step No.
Time(min)
%A
%B
1
0.01
95
5
2
2
85
15
3
5
80
20
4
5.01
40
60
6
6
40
60
7
6.01
95
5
8
7.5
95
5
Flow Rate
0.25 mL/min
Temperature
22°C
Detection
Tandem Mass Spec (MS-MS) @ (22°C)
Detection Info
Order Items Used in This Application
- 1. Phenobarbital
- 2. butalbital
- 3. Pentobarbital
- 4. Amobarbital
- 5. Secobarbital
-OEChem-06211003152D<br><br> 29 30 0 0 0 0 0 0 0999 V2000<br> 2.0000 0.2010 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4641 0.2010 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 -2.7990 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 -1.2990 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 -1.2990 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 0.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.2320 1.0670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.2320 1.0670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 -0.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 -0.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.2320 1.0670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 1.9330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.2320 1.0670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 -1.7990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.2320 2.7990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.7320 1.9330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.2320 2.7990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.8147 1.2790 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1244 1.6776 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.2320 1.6870 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1.6120 1.0670 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.2320 0.4470 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.3291 -1.6090 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.1350 -1.6090 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1120 1.9330 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.5420 0.5301 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.9220 3.3360 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.3520 1.9330 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.5420 3.3360 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1 9 2 0 0 0 0<br> 2 10 2 0 0 0 0<br> 3 14 2 0 0 0 0<br> 4 9 1 0 0 0 0<br> 4 14 1 0 0 0 0<br> 4 23 1 0 0 0 0<br> 5 10 1 0 0 0 0<br> 5 14 1 0 0 0 0<br> 5 24 1 0 0 0 0<br> 6 7 1 0 0 0 0<br> 6 8 1 0 0 0 0<br> 6 9 1 0 0 0 0<br> 6 10 1 0 0 0 0<br> 7 11 1 0 0 0 0<br> 7 18 1 0 0 0 0<br> 7 19 1 0 0 0 0<br> 8 12 2 0 0 0 0<br> 8 13 1 0 0 0 0<br> 11 20 1 0 0 0 0<br> 11 21 1 0 0 0 0<br> 11 22 1 0 0 0 0<br> 12 15 1 0 0 0 0<br> 12 25 1 0 0 0 0<br> 13 16 2 0 0 0 0<br> 13 26 1 0 0 0 0<br> 15 17 2 0 0 0 0<br> 15 27 1 0 0 0 0<br> 16 17 1 0 0 0 0<br> 16 28 1 0 0 0 0<br> 17 29 1 0 0 0 0<br>M END
Compound Name
Phenobarbital
CID
4763
Molecular Formula
C12H12N2O3
Molecular Weight
232
No. Hydrogen Bond Acceptors
3
No. Hydrogen Bond Donors
2
Similar Applications
Application Specific
Barbiturates from Whole Blood by Strata X (60mg/3cc) (TIC)
Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
23896
Application Specific
Barbiturates from urine by Strata X (60mg/3cc) (TIC)
Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
23895
Reversed Phase
TN Fig 7_7.5 min Pain Panel on Kinetex 2.6µm Biphenyl, 30x2.1mm
Kinetex 2.6 µm Biphenyl 100 Å, LC Column 30 x 2.1 mm, Ea
23566
Reversed Phase
Barbiturates by LCMS using Luna Omega 1.6um C18 50x2.1mm
Luna Omega 1.6µm C18 100Å, LC Column 50 x 2.1 mm, EA
23507
Reversed Phase
Barbiturates on Kinetex 2.6u EVO C18 50X2.1 mm
Kinetex 2.6 µm EVO C18 100 Å, LC Column 50 x 2.1 mm, Ea
23034
Reversed Phase
Barbiturates Mix on Kinetex 1.7u XB-C18 50x2.10mm using Waters Acquity UPLC System
Kinetex 1.7 µm XB-C18 100 Å, LC Column 50 x 2.1 mm, Ea
19801
Reversed Phase
Barbiturates in urine using Strata-X-Drug N and Kinetex C18 2.6µm 100x2.1mm
Kinetex 2.6 µm C18 100 Å, LC Column 100 x 2.1 mm, Ea
19724
Application Specific
Drug screen by MSD on a ZB-Drug1
Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
18175
Application Specific
Barbiturates from urine by Screen C on a ZB-Drug1
Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
18040
Application Specific
Barbiturates by MSD on a ZB-Drug1
Zebron ZB-Drug-1, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
17810
Barbiturates by MSD on a ZB-5MSi
17738
Standard
Barbiturates by MSD on a ZB-5MS
Zebron ZB-5MS, GC Cap. Column 10 m x 0.18 mm x 0.18 µm, Ea
17734
Barbiturates by MSD on a ZB-1MS
17599
Barbiturates by MSD on a ZB-XLB
17523
Standard
Drug Screen on ZB-XLB
Zebron ZB-XLB, GC Cap. Column 30 m x 0.25 mm x 0.50 µm, Ea
16463
Drug screen on ZB-5MSi
16421
High Temperature
Drug Screen on ZB-1HT
Zebron ZB-1HT, GC Cap. Column 30 m x 0.25 mm x 0.10 µm, Ea
16227
Standard
Common Drug Screen on ZB-50
Zebron ZB-50, GC Cap. Column 30 m x 0.25 mm x 0.25 µm, Ea
16012
Standard
Common Drug Screen on ZB-35
Zebron ZB-35, GC Cap. Column 30 m x 0.25 mm x 0.25 µm, Ea
16010
Standard
Common Drug Screen on ZB-5MS
Zebron ZB-5MS, GC Cap. Column 20 m x 0.18 mm x 0.18 µm, Ea
16009
Common Drug Screen on ZB-1MS
16008
Drug Screen on Zebron ZB-1MS 12m x 0.20mm x 0.33um
15869
Standard
Drug Screen on Zebron ZB-5MS 20m x 0.18mm x 0.18um
Zebron ZB-5MS, GC Cap. Column 20 m x 0.18 mm x 0.18 µm, Ea
15868
Drug Screen on Zebron ZB-1MS 20m x 0.18mm x 0.18um
15867
Reversed Phase
Extraction of Barbiturates from Urine on Strata™ X
Synergi 4 µm Max-RP 80 Å, LC Column 150 x 4.6 mm, Ea
14622